In The Chairman's Footsteps
Express Healthcare|December 2019
As Aster DM Healthcare enters its 33rd year on December 11, chairman Dr Azad Moopan prepares to hand over the reins to Deputy Managing Director Alisha Moopen by end 2022. Is the company on track to ramp up India revenues to at least one fourth of the business by 2025? And where does Ayushaman Bharat figure in their plans?
Viveka Roychowdhury
In The Chairman's Footsteps

From a single clinic in Dubai, UAE in 1987, to 25 hospitals, 116 clinics and 238 pharmacies in 32 years, across nine countries in the GCC region and India, the Aster DM Healthcare group is today one of the largest private healthcare service providers operating in multiple GCC states (12 hospitals, 108 clinics, 238 pharmacies). The group’s annual revenues crossed the $1 billion mark (approximately $1.14 billion/ Rs 7,963 crore in FY19).

The group entered India in 2001 and went public in February 2018. It is emerging as a significant player in India's healthcare market as well, with 13 hospitals and eight clinics. This October, the group announced the launch of its diagnostics labs business in India as well, re-affirming its aggressive growth strategy in the sub-continent.

According to a presentation made at an investor and analyst meet on August 22 this year, the GCC accounted for the lion's share (approximately $953 million) of Aster DM's FY19 revenues. Of the three revenue streams, hospitals accounted for 49 percent, pharmacies 27 percent and clinics 24 percent. (See Figure 1: Aster DM Healthcare - At a glance)

India revenues in FY19 were around 17 per cent, (approximately $188 million). Recipient of India's fourth highest civilian award the Padma Shri, Dr Azad Moopen, Chairman, Aster DM Healthcare has plans to ramp this up to at least 25 percent by 2025. And he is putting the team in place to do just that. (See Figure 2: Aster DM Healthcare - Revenue and EBITDA - FY19)

The recent quarterly figures were reassuring. In Q2FY20, Aster DM Healthcare’s revenue from operations improved by 14 percent to Rs 2,087 crore compared to Rs 1,837 crore in the same quarter last year. EBITDA (excluding other income and before Ind AS 116) increased by 39 percent Y-o-Y to Rs 174 crore compared to Rs125 crore in Q2FY19. EBITDA post Ind AS 116 impact for Q2FY20 is Rs 245 crore.

This story is from the December 2019 edition of Express Healthcare.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the December 2019 edition of Express Healthcare.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM EXPRESS HEALTHCAREView All
Healthcare Communication In India
Express Healthcare

Healthcare Communication In India

Dr Alexander Thomas, President, Association of Healthcare Providers - India (AHPI) and Divya Alexander, Research Consultant, in a first of a series provide detailed insights on healthcare communication that explores its different aspects in an Indian context

time-read
6 mins  |
March 2020
The growth story
Express Healthcare

The growth story

Himanshu Baid, Managing Director, Poly Medicure elucidates on how Poly Medicure has served the medical fraternity for over 22 years and owns more than 215 patents and continues to file new patents for new technologies and devices they are developing with the help of its R&D team

time-read
2 mins  |
March 2020
Main objective of Indian Joint Registry is to help patient safety, bring stability to the market
Express Healthcare

Main objective of Indian Joint Registry is to help patient safety, bring stability to the market

In the wake of several patients suffering from the impact of faulty hip implants, it is vital that India has a national joint registry to track such patients and avoid future episodes. Richard Armstrong, Head, Health Registries, Northgate Public Services tells Viveka Roychowdhury about the response to the Indian Joint Registry

time-read
4 mins  |
March 2020
Express Healthcare

UNDERSTANDING THE RELEVANCE OF HEALTHCARE RESEARCH

India as a nation has followed the west for decades when it comes to research-based treatments. The sun is fast setting on this methodology and there is a massive need to invest in healthcare research in the country

time-read
8 mins  |
March 2020
I have witnessed the steady technical advances in ultrasound
Express Healthcare

I have witnessed the steady technical advances in ultrasound

Dr BS Rama Murthy, Consultant Radiologist, Srinivasa Ultrasound Scanning Centre and Chief Patron, Medical Ultrasound Society of Karnataka, Coordinator – Fetal Foundation of India, talks about the evolution of ultrasound and how foetal imaging has improved over the years, in an interaction with Express Healthcare

time-read
4 mins  |
March 2020
Radiology has a bright future and has been at the forefront of healthcare
Express Healthcare

Radiology has a bright future and has been at the forefront of healthcare

Radiology has a major role to play when it comes to healthcare. Dr Piyush Saxena, Consultant Radiologist and Chief of MR imaging, Vishesh Hospital and Diagnostics, Indore, MP in an exclusive conversation with Express Healthcare disscuses the impact of radiology on healthcare and how newer innovations from GE Healthcare has helped improve healthcare delivery as well as patient comfort

time-read
4 mins  |
March 2020
The Pill For India's Ailing Medical Eductaion System
Express Healthcare

The Pill For India's Ailing Medical Eductaion System

Medical education in India is mired with a host of controversies and is trudging along a rough path.

time-read
6 mins  |
February 2020
RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai
Express Healthcare

RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai

Invites renowned Japanese cardiac interventionist, Dr Kinzo Ueda to India to share his experiences and insights with cardiologists at Apollo Hospitals and Sri Ramachandra Institute of Higher Education and Research

time-read
8 mins  |
February 2020
Roche Diagnostics partners with SRL Dr Avinash Phadke Lab
Express Healthcare

Roche Diagnostics partners with SRL Dr Avinash Phadke Lab

Roche’s first partner for cobas pro solution is SRL Dr Avinash Phadke Lab in Mumbai. The solution promises to offer greater automation, flexibility and simplified workflow to support better clinical outcomes for patients

time-read
5 mins  |
February 2020
Pharmacogenomics- Essential to end the era of trial and error medicine
Express Healthcare

Pharmacogenomics- Essential to end the era of trial and error medicine

Chandni Luthra, Co-Founder, FutureMed elucidates on the impact that trial and error has had on patients earlier, but in today's age adverse drug reactions is considered to be the fourth leading cause of death worldwide and has almost doubled in India in the last three years

time-read
3 mins  |
February 2020